Evidence-based document guides treatment decisions in patients with moderate to severe UC AMERICAN GASTROENTEROLOGICAL ASSOCIATION Bethesda, Maryland (Jan. 21, 2020) — Ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD) associated with an increased risk of colorectal cancer, can be life-altering for patients with moderate to severe disease activity. An increasing number of drugs are...